Workflow
都福(DOV)
icon
搜索文档
Dover Corporation 2025 Q3 - Results - Earnings Call Presentation (NYSE:DOV) 2025-10-23
Seeking Alpha· 2025-10-23 22:01
根据提供的文档内容,该文档不包含任何与公司或行业相关的实质性信息 无法进行核心观点总结或关键要点分析 [1]
Dover(DOV) - 2025 Q3 - Earnings Call Presentation
2025-10-23 21:30
业绩总结 - 2025年第三季度收入为21亿美元,同比增长5%[5] - 年初至今收入为60亿美元,同比增长3%[5] - 2025年第三季度调整后每股收益为2.62美元,同比增长15%[5] - 年初至今调整后每股收益为7.10美元,同比增长17%[5] - 2025年第三季度自由现金流为3.7亿美元,占收入的18%[5] - 年初至今自由现金流为6.31亿美元,占收入的11%[5] - 2025年第三季度订单总额为20亿美元,同比增长8%[5] - 年初至今订单总额为60亿美元,同比增长5%[5] - 2025年第三季度调整后EBITDA为6.1亿美元,同比增长12%[9] - 2025年第三季度调整后EBITDA利润率为26.1%,同比提升170个基点[5] 用户数据 - 第三季度2025年总有机收入增长为0.5%[26] - 年初至今增长为0.6%[26] - 第三季度2025年清洁能源与加油业务的有机收入增长为4.8%[26] - 第三季度2025年气候与可持续技术的有机收入下降6.5%[26] 未来展望 - 2025年全年的收入增长指导为4%-6%[24] - 2025年调整后每股收益指导为9.50至9.60美元[24] 新产品和新技术研发 - 2025年第三季度各业务部门均实现了可比利润率的增长[12] 市场扩张和并购 - 2025年第三季度的外汇影响为收入增长的1%[9] - 收购贡献为3%[9] 负面信息 - 第三季度2025年持续经营收益为3.03亿美元,较2024年同期的3.13亿美元下降了3.2%[28] - 第三季度2025年工程产品的预订金额为2.73亿美元,较2024年同期的2.85亿美元下降了4.2%[27] 其他新策略和有价值的信息 - 第三季度2025年调整后段EBITDA的增长率为22.6%至33.2%[29] - 第三季度2025年总收入为20.78亿美元,较2024年同期的19.84亿美元增长了4.7%[30]
Dover lifts 2025 profit outlook on AI infrastructure demand
Reuters· 2025-10-23 21:02
公司业绩与展望 - 工业设备制造商Dover上调了全年调整后利润预期 [1] - 公司股价因此上涨2% [1] 市场需求 - 公司对其工业设备的市场需求保持韧性抱有信心 [1] - 尽管存在关税不确定性 但需求依然强劲 [1]
Dover Corporation (DOV) Q3 Earnings Beat Estimates
ZACKS· 2025-10-23 20:46
季度业绩表现 - 季度每股收益为2.62美元,超出市场预期的2.50美元,同比增长15.4% [1] - 季度营收为20.8亿美元,低于市场共识预期0.6%,但较去年同期的19.8亿美元增长5.1% [2] - 本季度业绩为每股收益带来4.80%的正向惊喜,上一季度的正向惊喜为2.09% [1] 近期股价与市场预期 - 公司股价年初至今下跌约10.7%,而同期标普500指数上涨13.9% [3] - 业绩公布前,市场对公司的盈利预期修订趋势好坏参半,当前Zacks评级为3级(持有) [6] - 当前市场对下一季度的共识预期为每股收益2.46美元,营收20.7亿美元;本财年预期为每股收益9.46美元,营收80.8亿美元 [7] 行业比较与同业表现 - 公司所属的Zacks行业分类为“制造业-通用工业”,该行业在250多个Zacks行业中排名处于后41% [8] - 同业公司Middleby预计在即将公布的报告中,季度每股收益为2.03美元,同比下降12.9% [9] - Middleby的营收预期为9.5697亿美元,较去年同期增长1.5%,但其季度每股收益预期在过去30天内被下调了1.3% [9]
Dover rises after quarterly earnings beat estimates (DOV:NYSE)
Seeking Alpha· 2025-10-23 20:40
Dover (NYSE:DOV) rose 1.5% in premarket trading Thursday after the industrial manufacturer reported third-quarter results that beat Wall Street’s profit expectations but slightly missed on revenue. The company posted adjusted earnings of $2.62 a share, ahead of analysts’ forecasts for $2.51 a share. Revenue rose ...
Dover(DOV) - 2025 Q3 - Quarterly Report
2025-10-23 18:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 1-4018 (Exact name of registrant as specified in its charter) Delaware 53-0257888 (State or other jurisdiction of incorporation or orga ...
Dover(DOV) - 2025 Q3 - Quarterly Results
2025-10-23 18:38
Exhibit 99.1 Investor Contact: Media Contact: Jack Dickens Adrian Sakowicz Vice President - Investor Relations Vice President - Communications (630) 743-2566 (630) 743-5039 jdickens@dovercorp.com asakowicz@dovercorp.com DOVER REPORTS THIRD QUARTER 2025 RESULTS DOWNERS GROVE, Ill., October 23, 2025 — Dover (NYSE: DOV), a diversified global manufacturer, announced its financial results for the third quarter ended September 30, 2025. All comparisons are to the comparable period of the prior fiscal year, unless ...
Dover Reports Third Quarter 2025 Results
Prnewswire· 2025-10-23 18:30
Accessibility StatementSkip Navigation DOWNERS GROVE, Ill., Oct. 23, 2025 /PRNewswire/ -- Dover (NYSE: DOV), a diversified global manufacturer, announced its financial results for the third quarter ended September 30, 2025. All comparisons are to the comparable period of the prior fiscal year, unless otherwise noted. | Three Months Ended September 30, | Nine Months Ended September | | | | | | | --- | --- | --- | --- | --- | --- | --- | | | 30, | | | | | | | ($ in millions, except per share data) | 2025 | 2 ...
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
Prnewswire· 2025-10-23 06:40
Expert Systems' predictive pharmacology and AI-driven molecular modeling played a central role in Ratutrelvir's differentiation—optimizing pharmacokinetics, safety, and potency profiles to ensure broad clinical applicability across both therapeutic and preventive settings. Ratutrelvir (TRX01) demonstrates broad-spectrum in vitro activity against a range of SARS-CoV-2 virus strains and maintains exceptional potency profiles without requiring ritonavir co-administration. Its ritonavir- independent formulation ...
CDS Visual Launches New Version of its Immersive Connected Worker Platform
Prnewswire· 2025-10-22 04:15
Accessibility StatementSkip Navigation DOWNERS GROVE, Ill., Oct. 21, 2025 /PRNewswire/ --Â CDS Visual, part of Dover (NYSE: DOV) and a leading provider of visual-based digital software solutions for manufacturers, today announced the launch of CDS Mentor3.0, a new version of its connected workforce platform that aims to unify the shop floor lifecycle through digital work instruction authoring, execution, quality, skills management and real-time insights. CDS Mentor 3.0 is a cloud-based, AI-powered software ...